Thyropins - new structurally related proteinase inhibitors

Biological Chemistry

Volumn 379, Issue 2, 1998, Pages 105-111

  Lenarčič, Brigita ^a   Bevec, Tadeja ^a  

^a JO EF STEFAN INSTITUTE   (Slovenia)

Author keywords

Cysteine proteinase inhibitor; IGFBP; Invariant chain; MHC class II; p41; Thyroglobulin type 1 domain

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEINASE INHIBITOR; THYROGLOBULIN; THYROPIN; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW;

ANIMALS; BASE SEQUENCE; CYSTEINE PROTEINASE INHIBITORS; HUMANS; MOLECULAR SEQUENCE DATA; STRUCTURE-ACTIVITY RELATIONSHIP; THYROGLOBULIN;

EID: 0038835365     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Abrahamson, M., Mason, R.W., Hansson, H., Buttle, D.J., Grubb, A., and Ohlsson, K. (1991). Human cystatin C. Role of the N-terminal segment in the inhibition of human cysteine proteinases and in its inactivation by leucocyte elastase. Biochem. J. 273, 621-626.
2. Allander, S.V., Larsson, C., Ehrenborg, E., Suwanichkul, A., Weber, G., Morris, S.L., Bajalica, S., Kiefer, M.C., Luthman, H., and Powell, D.R. (1994). Characterization of the chromosomal gene and promoter for human insulin-like growth factor binding protein-5. J. Biol. Chem. 269, 10891-10898.
3. Alliel, P.M., Perin, J.P., Jolies, P., and Bonnet, F.J. (1993). Testican, a multidomain testicular proteoglycan resembling modulators of cell social behaviour. Eur. J. Biochem. 214, 347-350.
4. Arunachalam, B., Lamb, C.A., and Cresswell, P. (1994). Transport properties of free and MHC class II-associated oligomers containing different isoforms of human invariant chain. Int. Immunol. 6, 439-451.
5. Barrett, A.J., Rawlings, N.D., Davies, M.E., Machleidt, W., Salvesen, G., and Turk, V. (1986). Cysteine proteinase inhibitors of cystatin superfamily. In: Proteinase Inhibitors, A.J. Barrett and G. Salvesen, eds. (Amsterdam, New York: Elsevier), pp. 515-569.
6. + T cells. Crit. Rev. Immunol. 16, 359-379.
7. Bevec, T., Stoka, V., Pungerčič, G., Dolenc, I., and Turk, V. (1996). Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L. J. Exp. Med. 183, 1331-1338.
8. Bevec, T., Stoka, V., Pungerčič, G., Cazzulo, J.J., and Turk, V. (1997). A fragment of the major histocompatibility complex class p41 II-associated invariant chain inhibits cruzipain, the major cysteine proteinase from Trypanosoma cruzi. FEBS Lett. 401, 259-261.
9. Binkert, C., Margot, J.B., Landwehr, J., Heinrich, G., and Schwander, J. (1992). Structure of the human insulin-like growth factor binding protein-2 gene. Mol. Endocrinol 6, 826-836.
10. Bjork, I., Pol, E., Raub-Segall, E., Abrahamson, M., Rowan, A.D., and Mort, J.S. (1994). Differential changes in the association and dissociation rate constants for binding of cystatins to target proteinases occurring on N-terminal truncation of the inhibitors indicate that the interaction mechanism varies with different enzymes. Biochem. J. 299, 219-225.
11. Bode, W., Engh, R., Musil, D., Thiele, U., Huber, R., Karshikov, A., Brzin, J., Kos, J., and Turk, V. (1988). The 2.0 Å X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. EMBO J. 7, 2593-2599.
12. Cataldo, A.M., Paskevich, P.A., Kominami, E., and Nixon, R.A. (1991). Lysosomal hydrolases of different classes are abnormally distributed in brains of patient with Alzheimer disease. Proc. Natl. Acad. Sci. USA 88, 10988-11002.
13. Chernausek, S.D., Smith, C.E., Duffin, K.L., Busby, W.H., Wright, G., and Clemmons, D.R. (1995). Proteolytic cleavage of insulin-like growth factor binding protein 4 (IGFBP-4). Localization of cleavage site to non-homologous region of native IGFBP-4. J. Biol. Chem. 270, 11377-11382.
14. Conover, C.A., Kiefer, M.C., and Zapf, J. (1993a). Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts. Insulin-like growth factor dependence and biological studies. J. Clin. Invest. 91, 1129-1137.
15. Conover, C.A., Clarkson, J.T., and Bale, L.K. (1993b). Phorbol ester tumor promoters regulate insulin-like growth factor-binding protein-4 proteolysis. Endocrinology 133, 1347-1351.
16. Cygler, M., Sivaraman, J., Grochluski, P., Coulumbe, R., Storer, A.C., and Mort, J.S. (1996). Structure of rat procathepsin B: model for inhibition of cysteine proteinase activity by proregion. Structure 4, 405-416.
17. Delaissé, J.M., and Vaes, G. (1992). Mechanism of mineral solubilization and matrix degradation in osteoclastic bone resorbtion. In: Biology and Physiology of the Osteoclasts, B.R. Rifkin, and C.V. Gay, eds. (Boca Raton, FL, USA: CRC Press), pp. 289-314.
18. Delaissé, J.M., Ledent, P., and Vaes, G. (1991). Collagenolytic cysteine proteinases of bone tissue. Cathepsin B, (pro)cathepsin L and a cathepsin L-like 70 kDa proteinase. Biochem. J. 279, 167-174.
19. Durkin, M.E., Wewer, U.M., and Chung, A.E. (1995). Exon organization of the mouse entactin gene corresponds to the structural domains of the polypeptide and has regional homology to the low-density lipoprotein receptor gene. Genomics 26, 219-228.
20. Esser, R.E., Angelo, R.A., Murphey, M.D., Watts, L.M., Thornburg, L.P., Palmer, J.T., Talhouk, J.W., and Smith, R.E. (1994). Cysteine proteinase inhibitors decrease articular cartilage and bone destruction in chronic inflammatory arthritis. Arthritis Rheum. 37, 236-247.
21. Fineschi, B., and Miller, J. (1997). Endosomal proteases and antigen processing. TIBS 22, 377-382.
22. Fineschi, B., Arneson, L.S., Naujokas, M.F., and Miller, J. (1995). Proteolysis of major histocompatibility complex class II-associated invariant chain is regulated by the alternatively spliced gene product, p41. Proc. Natl. Acad. Sci. USA 92, 10257-10261.
23. Fineschi, B., Sakaguchi, K., Appella, E., and Miller, J. (1996). The proteolytic environment involved in MHC class II-restricted antigen presentation can be modulated by the p41 form of invariant chain. J. Immunol. 157, 3211-3215.
24. Fowlkes, J., and Freemark, M. (1992). Evidence for a novel insulin-like growth factor (IGF)-dependent protease regulating IGF-binding protein-4 in dermal fibroblasts. Endocrinology 131, 2071-2076.
25. Fowlkes, J.L., Serra, D.M., Rosenberg, C.K., and Thrailkill, K.M. (1995). Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) functions as an IGF-reversible inhibitor of IGFBP-4 proteolysis. J. Biol.Chem. 270, 27481-27488.
26. Fowlkes, J.L., Thrailkill, K.M., George-Nascimento, C., Rosenberg, C.K., and Serra, D.M. (1997). Heparin-binding, highly basic regions within the thyroglobulin type-1 repeat of insulin-like growth factor (IGF)-binding proteins (IGFBPs) -3, -5, and -6 inhibit IGFBP-4 degradation. Endocrinology 138, 2280-2285.
27. Gõ, M. (1981). Correlation of DNA exonic regions with protein structural units in haemoglobin. Nature 291, 90-92.
28. Gõ, M. (1983). Modular structural units, exons, and function in chicken lysozyme. Proc. Natl. Acad. Sci. USA 80, 1964-1968.
29. Jones, J.I., and Clemmons, D.R. (1995). Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16, 3-34.
30. Jones, J.I., D'Ercole, A.J., Camacho-Hubner, C., and Clemmons, D.R. (1991). Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I. Proc. Natl. Acad. Sci. USA 88, 7481-7485.
31. Jones, P.P., Murphy, D.B., Hewgill, D., and McDevitt, M.O. (1978). Detection of a common polypeptide chain in I-A and I-E subregion immunoprecipitates. Immunochemistry 16, 51-60.
32. Katunuma, N., Kakegawa, H., Matsunaga, Y., and Saibara, T. (1994). Immunological significances of invariant chain from the aspect of its structural homology with the cystatin family. FEBS Lett. 349, 265-269.
33. Koch, N., Lauer, W., Habicht, J., and Dobberstein, B. (1987). Primary structure of the gene for the murine Ia antigen-associated invariant chains (Ii). An alternatively spliced exon encodes a cysteine rich domain highly homologous to a repetitive sequence of thyroglobulin. EMBO J. 6, 1677-1683.
34. Kvist, S., Wiman, K., Claesson, L., Peterson, P.A., and Dobberstein, B. (1982). Membrane insertion and oligomeric assembly of HLA-DR histocompatibility antigens. Cell 29, 61-69.
35. Lenarčič, B., Križaj, I., Žunec, P., and Turk, V. (1996). Differences in specificity for the interactions of stefins A, B and D with cysteine proteinases. FEBS Lett. 395, 113-118.
36. Lenarčič, B., Ritonja, A., Štrukelj, B., Turk, B., and Turk, V. (1997). Equistatin, a new inhibitor of cysteine proteinases from Actinia equina, is structurally related to thyroglobulin type-1 domain. J. Biol. Chem. 272, 13899-13903.
37. Linnenbach, A.J., Seng, B.A., Wu, S., Robbins, S., Scollon, M., Pyre, J.J., Druck, T., and Huebner, K. (1993). Retroposition in a family of carcinoma-associated antigen genes. Mol. Cell. Biol. 13, 1507-1515.
38. Malthiery, Y., and Lissitzky, S. (1987). Primary structure of human thyroglobulin deduced from the sequence of its 8448-base complementary DNA. Eur. J. Biochem. 165, 491-498.
39. Mann, K., Deutzmann, R., Aumailley, M., Timpl, R., Raimondi, L., Yamada, Y., Pan, T.C., Conway, D., and Chu, M.L. (1989). Amino acid sequence of mouse nidogen, a multidomain basement membrane protein with binding activity for laminin, collagen IV and cells. EMBO J. 8, 65-72.
40. McCoy, K., Gal, S., Schwartz, R.H., and Gottesman, M.M. (1988). An acid protease secreted by transformed cells interferes with antigen processing. J. Cell. Biol. 106, 1879-1884.
41. McKnight, A.J., Mason, D.W., and Barclay, A.N. (1989). Sequence of a rat MHC class II-associated invariant chain cDNA clone containing a 64 amino acid thyroglobulin-like domain. Nucleic Acids Res. 17, 3983-3984.
42. Mercken, L. Simons, M.J., De Martynoff, G., Swillens, S., and Vassart, G. (1985). Presence of hormonogenic and repetitive domains in the first 930 amino acids of bovine thyroglobulin as deduced from the cDNA sequence. Eur. J. Biochem. 147, 59-64.
43. Molina, F., Bouanani, M., Pau, B., and Granier, C. (1996a). Characterization of the type-1 repeat from thyroglobulin, a cysteine-rich module found in proteins from different families. Eur. J. Biochem. 240, 125-133.
44. Molina, F., Pau, B., and Granier, C. (1996b). Thetype-1 repeats of thyroglobulin regulate thyroglobulin degradation and T3, T4 release in thyrocytes. FEBS Lett. 391, 229-231.
45. Morabito, M.A., and Moczydlowski, E. (1994). Molecular cloning of bullfrog saxiphilin: a unique relative of the transferrin family that binds saxitoxin. Proc. Natl. Acad. Sci. USA 91, 2478-2482.
46. Morabito, M.A., and Moczydlowski, E. (1995). Molecular cloning of bullfrog saxiphilin: a unique relative of the transferrin family that binds saxitoxin. Proc. Natl. Acad. Sci. USA 92, 6651.
47. Musil, D., Zućić, D., Turk, D., Engh, R.A., Mayr, I., Huber, R., Popovič, T., Turk, V., Towatari, T., Katunuma, N., and Bode, W. (1991). The refined 2.15 Å X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity. EMBO J. 10, 2321-2330.
48. Nakae, H., Sugano, M., Ishimori, Y., Endo, T., and Obinata, T. (1993). Ascidian entactin/nidogen. Implication of evolution by shuffling two kinds of cysteine-rich motifs. Eur. J. Biochem. 213, 11-19.
49. Ogrinc, T., Dolenc, I., Ritonja, A., and Turk, V. (1993). Purification of the complex of cathepsin L and the MHC class II-associated invariant chain fragment from human kidney. FEBS Lett. 336, 555-559.
50. Peterson, M., and Miller, J. (1992). Antigen presentation enhanced by the alternatively spliced invariant chain gene product p41. Nature 357, 596-598.
51. Pieters, J. (1997a). MHC class II compartments: specializedorganelles of the endocytic pathway in antigen presenting cells. Biol. Chem. 378, 751-758.
52. Pieters, J. (1997b). MHC class II restricted antigen presentation. Curr. Oppin. Immunol. 9, 89-96.
53. Podobnik, M., Kuhelj, R., Turk, V., and Turk, D. (1997). Crystal structure of the wild type human procathepsin B at 2.5 Å resolution reveals the native active site of papain-like cysteine protease zymogen. J. Mol. Biol. 271, 774-778.
54. Rodriguez, G.M., and Diment, S. (1995). Destructive proteolysis by cysteine proteases in antigen presentation of ovalbumin. Eur. J. Immunol. 25, 1823-1827.
55. Rechler, M.M. (1995). Non-receptor-binding proteins for insulin-like growth factors and other cytokines: modulators of peptide action. In: Molecular Enocrinology: Basic Concepts and Clinical Correlations. B.D. Weintraub, ed. (New York: Raven Press) pp. 155-180.
56. Salvesen, G., Parkes, C., Abrahamson, M., Grubb, A., and Barrett, A.J. (1986). Human low-Mr kininogen contains three copies of a cystatin sequence that are divergent in structure and in inhibitory activity for cysteine proteinases. Biochem. J. 234, 429-434.
57. Shimasaki, S., and Ling, N. (1991). Identification and molecular characterization of insulin-like growth factor binding proteins (IGRBP-1, -2, -3, -4, -5 and -6). Prog. Growth Factor Res. 3, 243-266.
58. Sloane, B.F., Moin, K., and Lah, T. (1994). Regulation of lysosomal endopeptidases in malignant neoplasia. In: Biochemical and Molecular Aspects of Selected Cancers, Vol. 2. T.G. Pretlow, and T.P. Pretlow, eds., (San Diego, USA: Academic Press), pp. 411-466.
59. Strubin, M., Long, E.O., and Mach, B. (1986). Two forms of the Ia antigen-associated invariant chain result from alternative initiations at two in-phase AUGs. Cell 47, 619-625.
60. Stubbs, M., Laber, B., Bode, W., Huber, R., Jerala, R., Lenarčič, B., and Turk, V. (1990). The refined 2.4 Å X-ray crystal structure of recombin at human stefin B in complex with the cysteine proteinase papain: a novel type of proteinase inhibitor interaction. EMBO J. 9, 1939-1947.
61. Stumptner, P., and Benaroch, P. (1997). Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) region. EMBO J. 16, 5807-5818.
62. Szala, S., Froehlich, M., Scollon, M., Kasai, Y., Steplewski, Z., Koprowski, H., and Linnenbach, A.J. (1990). Molecular cloning of cDNA for the carcinoma-associated antigen GA733-2. Proc. Natl. Acad. Sci. USA 87, 3542-3546.
63. Turk D., Podobnik, M., Kuhelj, R., Dolinar, M., and Turk, V. (1996). Crystal structures of human procathepsin B at 3.2 and 3.3 Å resolution reveal an interaction motif between a papain-like cysteine protease and its propeptide. FEBS Lett. 384, 211-214.
64. Turk, V., and Bode, W. (1991). The cystains: protein inhibitors of cysteine proteinases. FEBS Lett. 285, 213-219.
65. Turk V., Podobnik, M., Lenarčič, B., Bevec, T., Stoka, V., Turk, B., and Turk, D. (1997). New aspects of the regulation of activity of cysteine proteinases. In: Medical Aspects of Proteases and Protease Inhibitors, Katunuma, N., Kido, H., Fritz, H., Travis, J. eds. (Amsterdam, The Netherlands: IOS Press), pp. 3-14.
66. Vidard, L., Rock, K.L., and Benacerraf, B. (1991). The generation of immunogenic peptides can be selectively increased or decreased by proteolytic enzyme inhibitors. J. Immunol. 147, 1786-1791.
67. Wang, P.H., Do, Y.S., Macaulay, L., Shinagawa, T., Anderson, P.W., Baxter, J.D., and Hsueh, W.A. (1991). Identification of renal cathepsin B as a human prorenin-processing enzyme. J. Biol. Chem. 266, 12633-12638.
68. Weenink, S.M., and Gautam, A.M. (1997). Antigen presentation by MHC class II molecules. Immunol. Cell Biol. 75, 69-81.
69. Yamashita, M., and Konagaya, S. (1991). Cysteine protease inhibitor in egg of chum salmon. J. Biochem. (Tokyo) 110, 762-766.
70. Yamashita, M., and Konagaya, S. (1996). A novel cysteine protease inhibitor of the egg of chum salmon, containing a cysteine-rich thyroglobulin-like motif. J. Biol. Chem. 271, 1282-1284.